Yes, enhancing drug selectivity can significantly reduce toxicity. By accurately targeting only the disease-causing entity, the likelihood of affecting other biological processes is minimized. This precision reduces the incidence of side effects and enhances the overall safety profile of the drug. For example, selective inhibitors of specific enzymes in cancer cells can minimize damage to healthy cells, thereby reducing the adverse effects commonly associated with cancer therapies.
